India
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -426.99 M
|
March 31, 2024 | USD 13.57 | 1.28% |
|
India |
|
2 |
USD -328.92 M
|
March 31, 2024 | USD 15.45 | 0.33% |
|
India |
|
3 |
USD -263.98 M
|
March 31, 2024 | USD 20.46 | 1.52% |
|
India |
|
4 |
USD -231.58 M
|
March 31, 2024 | USD 4.48 | 6.30% |
|
India |
|
5 |
USD -161.77 M
|
March 31, 2024 | USD 16.73 | 0.74% |
|
India |
|
6 |
USD -159.22 M
|
March 31, 2024 | USD 4.73 | 0.12% |
|
India |
|
7 |
USD -152.22 M
|
March 31, 2024 | USD 11.85 | 8.40% |
|
India |
|
8 |
USD -136.29 M
|
March 31, 2024 | USD 77.49 | -1.80% |
|
India |
|
9 |
USD -120.25 M
|
March 31, 2024 | USD 69.21 | 4.65% |
|
India |
|
10 |
USD -116.87 M
|
March 31, 2024 | USD 9.22 | 1.12% |
|
India |
|
11 |
USD -116.37 M
|
March 31, 2024 | USD 14.93 | 1.77% |
|
India |
|
12 |
USD -112.99 M
|
March 31, 2024 | USD 7.67 | 0.27% |
|
India |
|
13 |
USD -111.37 M
|
March 31, 2024 | USD 24.89 | 0.15% |
|
India |
|
14 |
USD -108.69 M
|
March 31, 2024 | USD 11.56 | 2.72% |
|
India |
|
15 |
USD -107.71 M
|
March 31, 2024 | USD 17.52 | 1.42% |
|
India |
|
16 |
USD -107.63 M
|
March 31, 2024 | USD 11.12 | 4.25% |
|
India |
|
17 |
USD -94.23 M
|
March 31, 2024 | USD 12.53 | 0.37% |
|
India |
|
18 |
USD -85.37 M
|
March 31, 2024 | USD 2.71 | 1.14% |
|
India |
|
19 |
USD -81.32 M
|
March 31, 2024 | USD 6.56 | 1.75% |
|
India |
|
20 |
USD -77.61 M
|
March 31, 2024 | USD 7.15 | 0.36% |
|
India |
|
21 |
USD -68.14 M
|
March 31, 2024 | USD 8.29 | 2.86% |
|
India |
|
22 |
USD -58.99 M
|
March 31, 2024 | USD 9.56 | 0.73% |
|
India |
|
23 |
USD -51.89 M
|
March 31, 2024 | USD 37.58 | 0.68% |
|
India |
|
24 |
USD -51.23 M
|
March 31, 2024 | USD 3.76 | 0.04% |
|
India |
|
25 |
USD -49.31 M
|
March 31, 2024 | USD 18.35 | 0.69% |
|
India |
|
26 |
USD -46.75 M
|
March 31, 2024 | USD 19.28 | -1.41% |
|
India |
|
27 |
USD -45.84 M
|
March 31, 2024 | USD 30.80 | 2.84% |
|
India |
|
28 |
USD -45.63 M
|
March 31, 2024 | USD 6.74 | 2.92% |
|
India |
|
29 |
USD -42.39 M
|
March 31, 2024 | USD 16.98 | -3.69% |
|
India |
|
30 |
USD -40.69 M
|
March 31, 2024 | USD 14.52 | 3.84% |
|
India |
|
31 |
USD -39.26 M
|
March 31, 2024 | USD 11.66 | 0.86% |
|
India |
|
32 |
USD -36.36 M
|
March 31, 2024 | USD 3.00 | 2.25% |
|
India |
|
33 |
USD -34.45 M
|
March 31, 2024 | USD 12.00 | 2.40% |
|
India |
|
34 |
USD -33.68 M
|
March 31, 2024 | USD 23.42 | 2.77% |
|
India |
|
35 |
USD -33.40 M
|
March 31, 2024 | USD 11.92 | 0.63% |
|
India |
|
36 |
USD -33.21 M
|
March 31, 2024 | USD 29.54 | -1.50% |
|
India |
|
37 |
USD -32.87 M
|
March 31, 2024 | USD 4.56 | 4.65% |
|
India |
|
38 |
USD -32.62 M
|
March 31, 2024 | USD 8.37 | 0.98% |
|
India |
|
39 |
USD -31.62 M
|
March 31, 2024 | USD 19.80 | 0.45% |
|
India |
|
40 |
USD -31.34 M
|
March 31, 2024 | USD 20.35 | -1.23% |
|
India |
|
41 |
USD -31.09 M
|
March 31, 2024 | USD 60.83 | 0.86% |
|
India |
|
42 |
USD -27.14 M
|
March 31, 2024 | USD 4.85 | -0.49% |
|
India |
|
43 |
USD -25.90 M
|
March 31, 2024 | USD 15.79 | 3.81% |
|
India |
|
44 |
USD -25.04 M
|
March 31, 2024 | USD 2.98 | 3.96% |
|
India |
|
45 |
USD -24.48 M
|
March 31, 2024 | USD 4.21 | 4.98% |
|
India |
|
46 |
USD -23.83 M
|
March 31, 2024 | USD 7.55 | -0.88% |
|
India |
|
47 |
USD -23.25 M
|
March 31, 2024 | USD 9.99 | 4.37% |
|
India |
|
48 |
USD -22.26 M
|
March 31, 2024 | USD 5.77 | 2.41% |
|
India |
|
49 |
USD -22.13 M
|
March 31, 2024 | USD 9.00 | 6.34% |
|
India |
|
50 |
USD -20.90 M
|
March 31, 2024 | USD 6.72 | 2.11% |
|
India |
The Health Care company in India with the highest Capital Expenditure is Aurobindo Pharma Limited (NSE: AUROPHARMA.NS) at USD -426.99 M.
The Health Care company in India with the lowest Capital Expenditure is Suven Life Sciences Limited (NSE: SUVEN.NS) at USD 0.00.
The top 10 Health Care companies in India by Capital Expenditure are Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Sun Pharmaceutical Industries Limited, Biocon Limited, Cipla Limited, Aarti Industries Limited, Piramal Enterprises Limited, Apollo Hospitals Enterprise Limited, Divi's Laboratories Limited and E.I.D.- Parry (India) Limited.
The bottom 10 Health Care companies in India by Capital Expenditure are Suven Life Sciences Limited, Lasa Supergenerics Limited, Biofil Chemicals and Pharmaceuticals Limited, Vaishali Pharma Limited, Bombay Super Hybrid Seeds Limited, Vineet Laboratories Limited, Jagsonpal Pharmaceuticals Limited, Brooks Laboratories Limited, Nureca Limited and Medico Remedies Limited.